Morgan Stanley’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$109K Sell
35,210
-926
-3% -$2.87K ﹤0.01% 6093
2025
Q1
$120K Sell
36,136
-965
-3% -$3.2K ﹤0.01% 5931
2024
Q4
$114K Sell
37,101
-10,095
-21% -$31K ﹤0.01% 6008
2024
Q3
$172K Sell
47,196
-12,881
-21% -$47K ﹤0.01% 5803
2024
Q2
$275K Buy
60,077
+13,530
+29% +$62K ﹤0.01% 5541
2024
Q1
$229K Sell
46,547
-45,563
-49% -$225K ﹤0.01% 5687
2023
Q4
$434K Buy
92,110
+43,859
+91% +$207K ﹤0.01% 5675
2023
Q3
$123K Buy
48,251
+13,712
+40% +$34.9K ﹤0.01% 5789
2023
Q2
$155K Buy
34,539
+60
+0.2% +$269 ﹤0.01% 5756
2023
Q1
$171K Buy
34,479
+14,550
+73% +$72.3K ﹤0.01% 5780
2022
Q4
$41.1K Sell
19,929
-424,093
-96% -$874K ﹤0.01% 6376
2022
Q3
$1.17M Buy
444,022
+413,267
+1,344% +$1.09M ﹤0.01% 4794
2022
Q2
$111K Buy
30,755
+8,427
+38% +$30.4K ﹤0.01% 6220
2022
Q1
$173K Buy
22,328
+4,534
+25% +$35.1K ﹤0.01% 5999
2021
Q4
$251K Sell
17,794
-84,475
-83% -$1.19M ﹤0.01% 5945
2021
Q3
$1.79M Buy
+102,269
New +$1.79M ﹤0.01% 4657